T cell and antibody responses to SARS‐CoV‐2: Experience from a French transplantation and hemodialysis center during the COVID‐19 pandemic
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Transplantation"
DOI: 10.1111/ajt.16348
Abstract: Immunosuppressed organ‐transplanted patients are considered at risk for severe forms of COVID‐19. Moreover, exaggerated innate and adaptive immune responses might be involved in severe progression of the disease. However, no data on the immune response… read more here.
Keywords: cell antibody; responses sars; sars cov; cell ... See more keywords
Short- and long-term T cell and antibody responses following Dexamethasone treatment in COVID-19.
Sign Up to like & getrecommendations! Published in 2023 at "JCI insight"
DOI: 10.1172/jci.insight.166711
Abstract: BACKGROUND After its introduction as standard-of-care for severe COVID-19, dexamethasone has been administered to a large number of patients globally. Detailed knowledge of its impact on the cellular and humoral immune response to SARS-CoV-2 remains… read more here.
Keywords: dexamethasone treatment; covid; cell antibody; dexamethasone ... See more keywords
Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years Old
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.812126
Abstract: CoronaVac is an inactivated SARS-CoV-2 vaccine that has been rolled out in several low and middle-income countries including Brazil, where it was the mainstay of the first wave of immunization of healthcare workers and the… read more here.
Keywords: cell; vaccinated individuals; cell antibody; antibody responses ... See more keywords